Redding, California - August 22, 2024
Enzyme-linked Immunosorbent Assay (ELISA) Market to be Worth $32.69 Billion by 2031
ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive) Offering (Analyzer, Software) Technology (Chemiluminescence, Colorimetry, Fluorescence) Application (Research, Diagnostic) End User - Global Forecast to 2031
Meticulous Research®—a leading global market research company, published a research report titled ELISA Market Size, Share, Forecast, & Trends Analysis by Type (Direct, Sandwich, Competitive) Offering (Analyzer, Software) Technology (Chemiluminescence, Colorimetry, Fluorescence) Application (Research, Diagnostic) End User—Global Forecast to 2031.
According to this latest publication from Meticulous Research®, the ELISA market is projected to reach $32.69 billion by 2031 at a CAGR of 6.1% from 2024 to 2031.The growth of this market is propelled by various factors, such as the rising burden of chronic & infectious diseases, the rising application of ELISA in clinical settings, advances in ELISA, and the increasing applications of ELISA among food industries. However, the possibility of false positive results and the high costs of ELISA antibody preparation restrain the growth of this market.
Furthermore, increasing research in developing countries, growing R&D activities for biomarker detection, and the increasing emphasis on vaccine development are expected to create growth opportunities for the players in this market. However, stringent regulations for the approval and use of alternative technologies for disease diagnosis are a major challenge impacting the market’s growth.
Key Players
The key players operating in the ELISA market are Thermo Fisher Scientific Inc. (U.S.), Merck KGaA (Germany), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Danaher Corporation (U.S.), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Abbott Laboratories (U.S.), bioMérieux SA (France), Revvity Inc. (U.S.), QuidelOrtho Corporation (U.S.), Becton, Dickinson and Company (U.S.), Repligen Corporation (U.S.), BioLegend (U.S.), and Bio-Techne Corporation (U.S.).
The ELISA market is segmented by Type (Direct ELISA, Indirect ELISA, Sandwich ELISA, and Competitive ELISA), Offering (Kits & Assays, Analyzers [by Mode {Fully Automated and Semi-automated}, by Type {Optical Grating ELISA Analyzers and Optical Filter ELISA Analyzers}], and Software), Technology (Chemiluminescence ELISA, Colorimetric ELISA, and Fluorescence ELISA), Application (Research Applications [Drug Discovery & Monitoring {Protein Quantification, Antibody Detection, and Biomarker Discovery}, and Vaccine Development], Diagnostic Applications [Infectious Diseases, Autoimmune Diseases, Oncology, and Other Diagnostic Applications], Food Testing, and Other Applications), End User (Pharmaceutical & Biotechnology Companies, Diagnostic Laboratories, CDMOs & CROs, Academic & Research Institutes, Food Laboratories, and Other End Users), and Geography. The study also evaluates industry competitors and analyzes the market at the regional and country levels.
Among the ELISA types studied in this report, in 2024, the indirect ELISA segment is expected to account for the largest share of 43.5% of the ELISA market. The large share of this segment is attributed to the high sensitivity of the indirect ELISA method. The diagnosis of diseases such as HIV and Lyme disease requires high sensitivity to reduce the chances of false positive results. Also, indirect ELISA is more cost-effective compared to other ELISA types due to the need for a smaller number of labeled antibodies. These factors contribute to the large share of this segment.
Among the ELISA offerings studied in this report, in 2024, the kits & assays segment is expected to account for the largest share of 85.2% of the ELISA market. The large share of this segment is attributed to the increased R&D activities for drug discovery and the rising use of ELISA kits in biomarker detection. Additionally, the demand for ELISA consumables in disease diagnostics is increasing due to the accuracy and flexibility offered by the technique. The wide availability of consumables, the recurring use of assays & kits, and the rising adoption of these kits among researchers to assess antigen concentration in unknown samples further contribute to the large share of this segment.
Among the ELISA technologies studied in this report, in 2024, the colorimetric ELISA segment is expected to account for the largest share of the ELISA market. The colorimetric method is preferred by researchers owing to its low sample consumption and simplicity. The substrates used in colorimetric detection are more economical and have higher sensitivity compared to other technologies. Thus, the increased affordability of the technology is increasing its adoption among research institutes and small laboratories. Additionally, detection using colorimetric absorbance technology is considered the best measurement method for the quantification of pure protein samples, which further supports the large share of this segment.
Among all the applications studied in this report, in 2024, the diagnostic applications segment is expected to account for the largest share of the ELISA market. ELISA is widely used in clinical diagnostics for the detection of infectious diseases, allergies, cancer, and autoimmune diseases, as well as drug discovery. The rising incidence of cancer is driving the use of ELISA for diagnosis. According to GLOBOCAN, the prevalence of cancer is expected to increase to 32.6 million cases by 2045 from 20 million cases in 2022. These factors are expected to contribute to the large market share of this segment.
Among all the end users studied in this report, in 2024, the diagnostic laboratories segment is expected to account for the largest share of the ELISA market. The large share of this segment is attributed to the high prevalence of chronic diseases, the increase in the number of diagnostic laboratories, and the rising adoption of ELISA test kits for disease diagnosis.
This research report analyzes major geographies and provides a comprehensive analysis of the ELISA market in North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea, Australia, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa.
Among all the geographies studied in this report, in 2024, North America is expected to account for the largest share of 37.7% of the ELISA market. North America’s large market share is attributed to the region’s advanced healthcare infrastructure, well-established research & clinical laboratories, substantial spending on R&D by pharmaceutical & biotechnology companies, and the presence of key market players. Additionally, the expansion of research and clinical laboratories by key players supports the region’s largest share. For instance, in October 2022, Thermo Fisher Scientific Inc. (U.S.) expanded its clinical research lab in Kentucky, U.S., with an investment of $59 million.
Download Sample Report Here @ https://www.meticulousresearch.com/download-sample-report/cp_id=5997
Key Questions Answered in the Report:
- Which are the high-growth market segments in terms of type, offering, technology, application, end user, and geography?
- What was the historical market size for ELISA products globally?
- What are the market forecasts and estimates for the period 2024–2031?
- What are the major drivers, restraints, opportunities, challenges, and trends in the ELISA market?
- Who are the major players in the ELISA market?
- What is the competitive landscape like, and who are the leading players in the ELISA market?
- What are the recent developments in the ELISA market?
- What are the growth strategies adopted by major players in the ELISA market?
- What are the key geographical trends, and which are the high-growth regions/countries?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
